Inventor · disambiguated record
Chang Soo Yun
Also filed as: YUN CHANG SOO
7 granted patents·7 pending applications·11 citations·filing 2014–2023
76Inventor score
Files withKOREA RES INST CHEMICAL TECH9AM SCIENCES INC2KANAPH THERAPEUTICS INC2KOREA RES INST OF BIOSCIENCE1
Top patents by PatentIndex Score
14 records- 0179US11192878B2Piperidine-2,6-dione derivative and use thereofKOREA RES INST CHEMICAL TECH·Filed 2018·Granted Dec 7, 2021·3 cites·5 claims
- 0277US11084824B2Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredientKOREA RES INST CHEMICAL TECH·Filed 2018·Granted Aug 10, 2021·2 cites·6 claims
- 0375US9499537B2Antiviral pyrrolopyridine derivatives and method for preparing the sameKOREA RES INST CHEMICAL TECH·Filed 2014·Granted Nov 22, 2016·3 cites·19 claims
- 0475US9266872B22-hydroxyarylamide derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredientKOREA RES INST OF BIOSCIENCE·Filed 2014·Granted Feb 23, 2016·2 cites·2 claims
- 0563US10053458B2Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredientKOREA RES INST CHEMICAL TECH·Filed 2015·Granted Aug 21, 2018·1 cites·10 claims
- 0655US2024252488A1Mlkl binding or degrading compound and pharmaceutical use thereofKOREA RES INST CHEMICAL TECH·Filed 2021·Application pending·0 cites
- 0750US2023248734A1Antiviral composition obtained through drug repositioningKOREA RES INST CHEMICAL TECH·Filed 2021·Application pending·0 cites
- 0850US2025161271A1Pharmaceutical composition for treating cancer, comprising anticancer agent and novel compound having inhibitory activity with respect to prostaglandin e2 receptorsKANAPH THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0948US2025235462A1Novel capsid assembly inhibitorsAM SCIENCES INC·Filed 2022·Application pending·0 cites
- 1048US2022105188A1Target protein eed degradation-inducing degraducer, preparation method thereof, and pharmaceutical composition for preventing or treating diseases related to eed, ezh2, or prc2, comprising same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2020·Application pending·0 cites
- 1148US2025009742A1Novel capsid assembly inhibitorsAM SCIENCES INC·Filed 2022·Application pending·0 cites
- 1242US2023365582A1Novel compounds having inhibitory activity on prostaglandin e2 receptor and uses thereofKANAPH THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1335US10369149B24-(2-amino-tetrahydronaphthalenyl)pyrimidine derivative, preparation method therefor, and pharmaceutical composition for preventing or treating cancer, containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2015·Granted Aug 6, 2019·0 cites·9 claims
- 1435US10100019B2N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2016·Granted Oct 16, 2018·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Chang Soo Yun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →